DEF: Avalon GloboCare 2026 Proxy: Reverse Split & Warrants

Avalon GloboCare Corp. schedules its 2026 Annual Meeting to vote on a reverse stock split, a new equity incentive plan, and the ratification of prior warrant issuances.

Summary

• The 2026 Annual Meeting is scheduled for June 9, 2026, to be held virtually.
• Key proposals include the election of four directors, ratification of M&K CPAS, PLLC as auditors, and approval of the 2026 Stock Incentive Plan.
• Stockholders will vote on the issuance of warrants related to a February 27, 2026, private placement.
• A proposal to authorize a reverse stock split at a ratio between 1-for-2 and 1-for-25 is included to address Nasdaq minimum bid price requirements.
• The company reported a net loss of $18,260,976 for the fiscal year 2025.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a defensive filing, primarily focused on survival measures such as a reverse stock split to avoid delisting and the ratification of dilutive warrant issuances.

Positives

• Successful completion of a private placement on February 27, 2026, to bolster capital.
• Sale of Avalon RT 9 properties to Chairman Wenzhao Lu for approximately $9 million, improving the balance sheet.
• Appointment of new independent directors to the Board and committees to strengthen corporate governance.

Negatives

• Significant net loss of $18,260,976 for the fiscal year 2025.
• Receipt of a Nasdaq deficiency notice regarding the minimum bid price requirement.
• Substantial dilution expected for existing shareholders upon the exercise of warrants and potential future equity issuances.

Risks

• Potential delisting from The Nasdaq Capital Market if the minimum bid price requirement is not met.
• Continued reliance on capital raises and potential for future dilution.
• Operational risks associated with the integration of the newly acquired RPM Interactive, Inc.
• Dependence on key personnel and potential impact of management changes.

Future Outlook

The company intends to focus on advancing its business and financial position, utilizing the 2026 Stock Incentive Plan to attract and retain talent, and seeking to maintain its Nasdaq listing through a potential reverse stock split.

Management Comments

• The Board believes the reverse stock split is necessary to increase the bid price of common stock to avoid delisting.
• The Board believes the 2026 Plan is critical to offer competitive equity compensation to attract and retain management.

Industry Context

StockSavvy.ai notes that Avalon GloboCare is navigating common challenges for small-cap biotech and technology firms, including maintaining Nasdaq compliance and managing cash burn through dilutive financing, which is a recurring theme in the current volatile market environment.

Comparison to Industry Standards

• The use of reverse stock splits to maintain Nasdaq listing compliance is a standard, albeit often negative, signal in the small-cap sector.
• The reliance on private placements with warrant coverage is consistent with financing strategies for early-stage healthcare and technology companies.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed.

Related Party Transactions

• Sale of Avalon RT 9 properties to Chairman Wenzhao Lu for $9 million.
• Exchange of Series A Preferred Stock for Series D Preferred Stock with Wenzhao Lu.
• Acquisition of RPM Interactive, Inc. involving Michael Mathews.

Stakeholder Impact

• Shareholders face potential dilution from warrant exercises and future equity grants.
• Shareholders may experience a reduction in share count if the reverse stock split is implemented.

Next Steps

• Hold the 2026 Annual Meeting on June 9, 2026.
• Implement reverse stock split if approved and deemed necessary by the Board.
• File Current Report on Form 8-K with final voting results.

Key Dates

Recommendation

The combination of a significant increase in net losses, the need for a reverse stock split to avoid delisting, and heavy dilution from warrant and preferred stock issuances suggests a challenging outlook for common shareholders.

Keywords

Avalon GloboCare, ALBT, Reverse Stock Split, Proxy Statement, Nasdaq, Private Placement, Equity Incentive Plan